Dementia in late-onset epilepsy
The Atherosclerosis Risk in Communities study
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective To determine the risk of dementia after the development of late-onset epilepsy.
Methods We used data from the Atherosclerosis Risk in Communities (ARIC) cohort study, which started in 1987 to 1989 with 15,792 mostly Black and White men and women from 4 US communities. We identified late-onset epilepsy (LOE; seizures starting at age 67 or later) from linked Medicare claims data. We used a Cox proportional hazards regression model to evaluate associations between LOE and dementia through 2017 as ascertained from neuropsychological testing, interviews, and hospital discharge surveillance, and we used multinomial logistic regression to assess the risk of dementia and mild cognitive impairment in the subset with full neuropsychological assessments available. We adjusted for demographics and vascular and Alzheimer disease risk factors.
Results Of 9,033 ARIC participants with sufficient Medicare coverage data (4,980 [55.1%] female, 1993 [22.1%] Black), 671 met the definition of LOE. Two hundred seventy-nine (41.6%) participants with and 1,408 (16.8%) without LOE developed dementia (p < 0.001). After a diagnosis of LOE, the adjusted hazard ratio for developing subsequent dementia was 3.05 (95% confidence interval 2.65–3.51). The median time to dementia ascertainment after the onset of LOE was 3.66 years (quartile 1–3, 1.28–8.28 years).
Interpretation The risk of incident dementia is substantially elevated in individuals with LOE. Further work is needed to explore causes for the increased risk of dementia in this growing population.
Glossary
- AD=
- Alzheimer disease;
- ARIC=
- Atherosclerosis Risk in Communities;
- BMI=
- body mass index;
- CI=
- confidence interval;
- CMS=
- Centers for Medicare & Medicaid Services;
- FFS=
- fee-for-service;
- HR=
- hazard ratio;
- ICD=
- International Classification of Diseases;
- LOE=
- late-onset epilepsy;
- MCI=
- mild cognitive impairment;
- RRR=
- relative risk ratio
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Editorial, page 1074
- Received May 14, 2020.
- Accepted in final form August 3, 2020.
- © 2020 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Research Article
Mortality in Patients With Late-Onset EpilepsyResults From the Atherosclerosis Risk in Communities StudyEmily L. Johnson, Gregory L. Krauss, Anna Kucharska-Newton et al.Neurology, July 19, 2021 -
Article
Periodontal disease and incident dementiaThe Atherosclerosis Risk in Communities Study (ARIC)Ryan T. Demmer, Faye L. Norby, Kamakshi Lakshminarayan et al.Neurology, July 29, 2020 -
Article
Association between white matter hyperintensities, cortical volumes, and late-onset epilepsyEmily L. Johnson, Gregory L. Krauss, Alexandra K. Lee et al.Neurology, January 25, 2019 -
Research Article
Association of Midlife Plasma Amyloid-β Levels With Cognitive Impairment in Late LifeThe ARIC Neurocognitive StudyKevin J. Sullivan, Chad Blackshear, Jeannette Simino et al.Neurology, August 04, 2021